ConductScience.org, home

Gene956

ENTPD3: ectonucleoside triphosphate diphosphohydrolase 3

Cite this record

ConductScience Library. ENTPD3: ectonucleoside triphosphate diphosphohydrolase 3. Genes, record 956. Release gene-search-2026-11-13-0.2.1, 13 Nov 2026. https://conductscience.org/library/genes/956

FollowSave as evidenceDownload JSON
Sources
13 sources
Release
gene-search-2026-11-13-0.2.1

Gene

Symbol
ENTPD3
HGNC
Name
ectonucleoside triphosphate diphosphohydrolase 3
HGNC
NCBI Gene ID
956
NCBI Gene
HGNC ID
HGNC:3365
HGNC
Ensembl
ENSG00000168032
NCBI Gene
Aliases
CD39L3, HB6, NTPDase-3
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
O75355Ectonucleoside triphosphate diphosphohydrolase 35290Ensembl, GeneID, HGNC

Source UniProt

Download CSV of proteins

Patents120

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
US 20260193644 A12026-07-093661O75355Espacenet
US 20260176598 A12026-06-25218O75355Espacenet
US 20260139247 A12026-05-211401O75355Espacenet
JP 2026507781 A2026-03-06127O75355Espacenet
JP 2026004568 A2026-01-1444702O75355Espacenet
JP 2026004568 A2026-01-1444703O75355Espacenet
EP 4641201 A22025-10-293661O75355Espacenet
JP 2025529142 A2025-09-041401O75355Espacenet
US 12371689 B22025-07-291401O75355Espacenet
US 12371689 B22025-07-291401O75355Espacenet

See all 120 patentsDownload CSV of patents

NIH grants337

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleENTPD3 papersNewest fiscal year
P30DK116073University of Colorado Anschutz Medical Campus DRC42025
U24DK098085Integrated Islet Distribution Program (U24) - 202142025
R01DK119482Role of Urothelial Purinergic Signaling in Diabetic Bladder Dysfunction32025
R01DK132387Local immune modulation for beta cell replacement therapy in type 1 diabetes32025
P01AI042288Immune Function and the Progression to Type 1 Diabetes22025
P30CA008748Cancer Center Support Grant22025
P30CA016086Cancer Center Support Grant22025
P30CA068485Cancer Center Support Grant22025
P30DK020593Vanderbilt Diabetes Research Center22025
P30EY001583P30 Core Grant For Vision Research22025

Source NIH's project files

See all 337 nih grantsDownload CSV of nih grants

Papers339

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Harmine selectively enhances human beta cell identity markers and function via protein kinase A pathways.Diabetologia202642766004PubTator, text miningPubMed
A genome-wide deletion map in 125,730 individuals for novel rare disease gene and variant discovery.medRxiv202642180369PubTator, text miningPubMed
Design, synthesis, and enzyme kinetic evaluation of oxadiazole derivatives as nucleoside triphosphate diphosphohydrolase (NTPDase) inhibitors: an integrated in vitro and in silico approach.RSC Adv202642052180PubTator, text miningPubMed
ENTPD3 as a novel regulator of endometrial receptivity: suppressing EMT via the ATP-P2Y2 axis in patients with recurrent implantation failure.Cell Mol Biol Lett202642014997PubTator, text miningPubMed
Beta cell-targeted PD-1 agonist inhibits cell-mediated autoimmunity in pancreas tissue slices.Sci Adv202641920992PubTator, text miningPubMed
Dysregulation of CD39/Ectonucleoside Triphosphate Diphosphohydrolase 1 Causes Urinary Bladder Dysfunction with Abnormal Smooth Muscle Contractility.FASEB J202641891871PubTator, text miningPubMed
FTO-CHRM3 axis regulates multiple myeloma progression: a machine learning-based identification.Ann Hematol202641870649PubTator, text miningPubMed
Gadoxetic Acid-enhanced MRI Radiomics Features of Tumor Margins for Predicting High-Risk Solitary Hepatocellular Carcinoma Aggressiveness and Prognosis.Radiol Imaging Cancer202641575341PubTator, text miningPubMed
Potent Competitive Inhibitors of Ecto-5'-nucleotidase (CD73) based on 6‑(Het)aryl-7-deazapurine Ribonucleoside 5'‑O‑Bisphosphonates.ACS Pharmacol Transl Sci202641536280PubTator, text miningPubMed
DNA methylation changes in thyroid cancer patients infected with SARS-CoV-2.Updates Surg202640490622PubTator, text miningPubMed

See all 339 papersDownload CSV of papers

None in this release

  • Drugs
  • Trials

Sources 13

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
  • USPTO's sequence listingsPublic domain in the US. Source: United States Patent and Trademark Office, www.uspto.gov
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
  • USPTO's sequence listingsUSPTO's sequence listings of patents and published applications, from its bulk data files. No license named for the files. USPTO's terms say "most government-produced materials appearing on this website are not subject to copyright restrictions within the United States and are therefore in the public domain", and ask that USPTO be given appropriate acknowledgement ("Source: United States Patent and Trademark Office, www.uspto.gov"). USPTO does not endorse ConductScience or this release. Read on 12 Nov 2026 at https://www.uspto.gov/terms-use-uspto-websites

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

Source: United States Patent and Trademark Office, www.uspto.gov. USPTO does not endorse ConductScience or this database.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/956

GET https://conductscience.org/api/genes/v1/956/patents?page=2